brimonidine tartrate has been researched along with genistein in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deth, RC; Jinsi, A | 1 |
| Deth, RC; Jinsi, A; Paradise, J | 1 |
| Ogihara, M | 1 |
| Roberts, RE | 1 |
| Kamata, K; Suenaga, H | 1 |
| Chatterjee, S; Freedman, RR; Furspan, PB | 1 |
1 trial(s) available for brimonidine tartrate and genistein
| Article | Year |
|---|---|
Increased tyrosine phosphorylation mediates the cooling-induced contraction and increased vascular reactivity of Raynaud's disease.
Topics: Adrenergic alpha-Agonists; Adult; Angiotensin II; Arterioles; Brimonidine Tartrate; Cold Temperature; Enzyme Inhibitors; Female; Genistein; Humans; Middle Aged; Phosphorylation; Protein-Tyrosine Kinases; Quinoxalines; Raynaud Disease; Serotonin; Signal Transduction; Skin; Skin Temperature; Tyrosine; Tyrphostins; Vasoconstriction; Vasoconstrictor Agents | 2004 |
5 other study(ies) available for brimonidine tartrate and genistein
| Article | Year |
|---|---|
Alpha 2-adrenoceptor-mediated vasoconstriction requires a tyrosine kinase.
Topics: Animals; Aorta; Brimonidine Tartrate; Cinnamates; Dose-Response Relationship, Drug; Genistein; Hydroquinones; Isoflavones; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Protein-Tyrosine Kinases; Quinoxalines; Rabbits; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Saphenous Vein; Vasoconstriction | 1995 |
A tyrosine kinase regulates alpha-adrenoceptor-stimulated contraction and phospholipase D activation in the rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Brimonidine Tartrate; Calcium Channel Agonists; Dose-Response Relationship, Drug; Enzyme Activation; Genistein; Isoflavones; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Pertussis Toxin; Phospholipase D; Potassium; Protein-Tyrosine Kinases; Quinoxalines; Rats; Receptors, Adrenergic, alpha; Virulence Factors, Bordetella | 1996 |
Cell-density-dependent expression of the alpha(2)-adrenergic response by epidermal growth factor (EGF) in primary cultures of adult rat hepatocytes.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Cell Count; Cells, Cultured; Colforsin; Cyclic AMP; Cycloheximide; Cytochalasin B; Epidermal Growth Factor; Genistein; Isoflavones; Liver; Male; Oxymetazoline; Pertussis Toxin; Protein Biosynthesis; Proteins; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Virulence Factors, Bordetella; Yohimbine | 1996 |
Role of the extracellular signal-regulated kinase (Erk) signal transduction cascade in alpha(2) adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Butadienes; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Forelimb; Genistein; Isoflavones; Mitogen-Activated Protein Kinases; Nifedipine; Nitriles; Potassium Chloride; Quinoxalines; Receptors, Adrenergic, alpha-2; Signal Transduction; Swine; Vasoconstriction; Vasodilator Agents; Veins; Verapamil | 2001 |
Lysophosphatidylcholine potentiates vascular contractile responses in rat aorta via activation of tyrosine kinase.
Topics: Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Brimonidine Tartrate; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Genistein; Lysophosphatidylcholines; Male; Muscle Contraction; Phosphorylation; Potassium; Protein-Tyrosine Kinases; Quinoxalines; Rats; Rats, Wistar; Vasoconstrictor Agents | 2002 |